PAWC
P.A.W. Capital Portfolio holdings
AUM
$51.9M
1-Year Return
46.14%
This Quarter Return
+3.47%
1 Year Return
+46.14%
3 Year Return
+74.13%
5 Year Return
+167.35%
10 Year Return
+839.74%
AUM
$79.5M
AUM Growth
-$15.9M
(-17%)
Cap. Flow
-$17.9M
Cap. Flow
% of AUM
-22.5%
Top 10 Holdings %
Top 10 Hldgs %
40.09%
Holding
78
New
4
Increased
18
Reduced
22
Closed
22
Top Buys
| 1 |
EMKR
Emcore Corp
EMKR
|
$2.32M |
| 2 |
ATTU
Attunity Ltd
ATTU
|
$2.09M |
| 3 |
QUOT
Quotient Technology Inc
QUOT
|
$1.88M |
| 4 |
Kratos Defense & Security Solutions
KTOS
|
$1.06M |
| 5 |
Mitek Systems
MITK
|
$895K |
Top Sells
| 1 |
PLPM
Planet Payment, Inc
PLPM
|
$2.79M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$1.73M |
| 3 |
RATE
Bankrate Inc
RATE
|
$1.67M |
| 4 |
Visa
V
|
$1.58M |
| 5 |
Meta Platforms (Facebook)
META
|
$1.54M |
Sector Composition
| 1 | Technology | 31.93% |
| 2 | Healthcare | 14.01% |
| 3 | Consumer Staples | 11.54% |
| 4 | Communication Services | 9.71% |
| 5 | Financials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
New Mountain Finance
NMFC
$1.13B
| $1.11M | 1.4% |
82,000
| – | – |
|
|
WIFI
27
DELISTED
Boingo Wireless, Inc.
WIFI
| $1.01M | 1.27% |
45,000
-5,000
| -10% | -$113K |
|
28
Galmed Pharmaceuticals
GLMD
$7.01M
| $961K | 1.21% |
583
| – | – |
|
|
CCXI
29
DELISTED
ChemoCentryx, Inc.
CCXI
| $952K | 1.2% |
160,000
| – | – |
|
30
Verizon
VZ
$186B
| $900K | 1.13% |
17,000
+2,000
| +13% | +$106K |
|
|
RDS.A
31
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $867K | 1.09% |
13,000
-2,000
| -13% | -$133K |
|
32
Altria Group
MO
$112B
| $786K | 0.99% |
11,000
| – | – |
|
33
TotalEnergies
TTE
$134B
| $774K | 0.97% |
14,000
-1,000
| -7% | -$55.3K |
|
34
Chevron
CVX
$318B
| $751K | 0.94% |
6,000
-500
| -8% | -$62.6K |
|
35
Philip Morris
PM
$251B
| $740K | 0.93% |
7,000
+1,000
| +17% | +$106K |
|
|
CASC
36
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $740K | 0.93% |
200,000
-40,000
| -17% | -$148K |
|
37
AbbVie
ABBV
$376B
| $725K | 0.91% |
7,500
-1,500
| -17% | -$145K |
|
38
Pfizer
PFE
$140B
| $724K | 0.91% |
21,080
| – | – |
|
39
PepsiCo
PEP
$201B
| $720K | 0.91% |
6,000
| – | – |
|
40
BP
BP
$88.4B
| $715K | 0.9% |
18,572
-3,605
| -16% | -$139K |
|
41
DuPont de Nemours
DD
$32.3B
| $712K | 0.9% |
4,957
-1,239
| -20% | -$178K |
|
42
GSK
GSK
$79.8B
| $709K | 0.89% |
16,000
+4,000
| +33% | +$177K |
|
43
Johnson & Johnson
JNJ
$431B
| $699K | 0.88% |
5,000
-500
| -9% | -$69.9K |
|
44
GE Aerospace
GE
$299B
| $698K | 0.88% |
8,346
+2,086
| +33% | +$174K |
|
45
Procter & Gamble
PG
$373B
| $689K | 0.87% |
7,500
| – | – |
|
46
Coca-Cola
KO
$294B
| $688K | 0.87% |
15,000
| – | – |
|
47
Abbott
ABT
$231B
| $685K | 0.86% |
12,000
-2,000
| -14% | -$114K |
|
48
Merck
MRK
$210B
| $675K | 0.85% |
12,576
+1,048
| +9% | +$56.3K |
|
49
Blackstone
BX
$133B
| $640K | 0.81% |
20,000
+5,000
| +33% | +$160K |
|
50
Weyerhaeuser
WY
$18.4B
| $635K | 0.8% |
18,000
-2,000
| -10% | -$70.6K |
|